{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "20338692",
  "DateCompleted": {
    "Year": "2011",
    "Month": "02",
    "Day": "02"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2010",
        "Month": "03",
        "Day": "24"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.psyneuen.2010.03.001"
    ],
    "Journal": {
      "ISSN": "1873-3360",
      "JournalIssue": {
        "Volume": "35",
        "Issue": "9",
        "PubDate": {
          "Year": "2010",
          "Month": "Oct"
        }
      },
      "Title": "Psychoneuroendocrinology",
      "ISOAbbreviation": "Psychoneuroendocrinology"
    },
    "ArticleTitle": "Metyrapone blunts stress-induced hyperthermia and increased locomotor activity independently of glucocorticoids and neurosteroids.",
    "Pagination": {
      "StartPage": "1299",
      "EndPage": "1310",
      "MedlinePgn": "1299-310"
    },
    "Abstract": {
      "AbstractText": [
        "Metyrapone, a cytochrome P(450) inhibitor used to inhibit corticosterone synthesis, triggers biological markers of stress and also reduces stress-induced anxiety-like behaviors. To address these controversial effects, 6 separate investigations were carried out. In a first set of investigations, abdominal temperature (T(abd)), spontaneous locomotor activity (A(S)) and electroencephalogram (EEG) were recorded in freely moving rats treated with either saline or 150 mg kg(-1) metyrapone. An increase in T(abd) and A(S) occurred in saline rats, while, metyrapone rats exhibited an immediate decrease, both variables returning to basal values 5h later. Concomitantly, the EEG spectral power increased in the gamma and beta 2 bands and decreased in the alpha frequency band, and the EMG spectral power increased. This finding suggests that metyrapone depressed stress-induced physiological response while arousing the animal. In a second step, restraint stress was applied 5h after injection. Metyrapone significantly blunted the stress-induced T(abd) and A(S) rise, without affecting the brain c-fos mRNA increase. Corticosterone (5 and 40 mg kg(-1)) injected concomitantly to metyrapone failed to reverse the observed metyrapone-induced effects in T(abd) and A(S). Finasteride (50 mg kg(-1)), which blocks neurosteroid production, was also unable to block these effects. In conclusion, metyrapone acutely reduced stress-induced physiological response in freely behaving rats independently from glucocorticoids and neurosteroids."
      ],
      "CopyrightInformation": "Copyright \u00a9 2010 Elsevier Ltd. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "D\u00e9partement des environnements op\u00e9rationnels, Institut de Recherche Biom\u00e9dicale des Arm\u00e9es (IRBA-CRSSA), La Tronche, France. jb.drouet@crssa.net"
          }
        ],
        "LastName": "Drouet",
        "ForeName": "Jean-Baptiste",
        "Initials": "JB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Michel",
        "ForeName": "Virginie",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Peinnequin",
        "ForeName": "Andr\u00e9",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Alonso",
        "ForeName": "Antonia",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Fidier",
        "ForeName": "Nadine",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Maury",
        "ForeName": "Renaud",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Buguet",
        "ForeName": "Alain",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Cespuglio",
        "ForeName": "Raymond",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Canini",
        "ForeName": "Fr\u00e9d\u00e9ric",
        "Initials": "F"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Psychoneuroendocrinology",
    "NlmUniqueID": "7612148",
    "ISSNLinking": "0306-4530"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antimetabolites"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Glucocorticoids"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Neurotransmitter Agents"
    },
    {
      "RegistryNumber": "ZS9KD92H6V",
      "NameOfSubstance": "Metyrapone"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Algorithms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Antimetabolites"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Down-Regulation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Evaluation, Preclinical"
    },
    {
      "QualifierName": [
        "etiology",
        "physiopathology",
        "prevention & control"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [
        "metabolism",
        "physiology"
      ],
      "DescriptorName": "Glucocorticoids"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Metyrapone"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Motor Activity"
    },
    {
      "QualifierName": [
        "metabolism",
        "physiology"
      ],
      "DescriptorName": "Neurotransmitter Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats, Sprague-Dawley"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Stress, Physiological"
    }
  ]
}